Table 3.
Linear regression of faecal egg count against individual risk factors for Strongylus vulgaris infection.
| Investigated parameter | Rel. effect (95% aC.I.) | p-value | |
|---|---|---|---|
| Year of the study | 2016 | REF * | 0.79 |
| 2017 | 1.0 (0.7-1.5) | ||
| Region | South | REF | 0.49 |
| Central | 1.0 (0.7-1.5) | ||
| North | 0.8 (0.5-1.2) | ||
| Age group | 0-5 | REF | 0.016 |
| 6-10 | 0.8 (0.5-1.1) | ||
| 11-15 | 0.6 (0.4-0.8) | ||
| 16-20 | 0.5 (0.4-0.8) | ||
| 21- | 0.7 (0.4-1.1) | ||
| Time since deworming | 6 months | REF | 0.84 |
| 8 months | 1.2 (0.7-2.1) | ||
| 10 months | 1.3 (0.7-2.3) | ||
| 12 months | 1.3 (0.8-2.1) | ||
| 24 months | 1.2 (0.6-2.2) | ||
| 48 months | 1.0 (0.6-1.8) | ||
| Anthelmintic drug | IVMb | REF | 0.66 |
| BZc | 2.0 (0.5-7.9) | ||
| MOXd | 1.3 (0.9-2.1) | ||
| PYRe | 1.0 (0.4-2.4) | ||
| Deworming routine | FEC only | REF | 0.23 |
| FEC and cultivation for S. vulgaris | 0.8 (0.6-1.2) | ||
| Deworming 1-4 times/year | 1.2 (0.8-1.9) |
aconfidence interval b reference sample used to calculate odds ratio within each investigated parameter b ivermectin c benzimidazole d moxidectin e pyrantel.